Page last updated: 2024-11-01

nifedipine and Urolithiasis

nifedipine has been researched along with Urolithiasis in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Urolithiasis: Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davenport, K1
Timoney, AG1
Keeley, FX1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy and Endoscopic-Guided Percutaneous Nephrolithotomy: A Randomized Double-Blind Placebo Controlled Trial of Tadalafil, Tamsulosin and Combination[NCT03229889]Phase 4220 participants (Anticipated)Interventional2017-06-07Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for nifedipine and Urolithiasis

ArticleYear
Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study.
    Urological research, 2007, Volume: 35, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Cyclooxygenase Inhibitors; Diclofenac; Female; Humans; Male; Mi

2007